Skip to main content

Corient Private Wealth LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1948780 MIAMI, FL

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$5,932,910
+$5,173,127 QoQ
Shares Held
45,035
+740.7% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 98.86454537374456.ToString("F0")% Shared 0.ToString("F0")% None 1.135454626255444.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Corient Private Wealth LLC holds $108,358,523 across 27 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (5.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NBIX
Neurocrine Biosciences Inc
This page
45,035 $5,932,910

All Filings in NBIX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,932,910 45,035
2025-12-31 $759,783 5,357
2025-09-30 $562,221 4,005
2025-06-30 $612,235 4,871
2025-03-31 $464,519 4,200
2024-12-31 $1,082,034 7,927
2024-09-30 $556,858 4,833
2024-06-30 $610,704 4,436
2024-03-31 $526,716 3,819
2023-12-31 $419,260 3,182
2023-09-30 $355,387 3,159
2023-06-30 $287,520 3,049
2023-03-31 $525,736 5,194